Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Moldova: Prevalence of hypertension, female

Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
38.5%
in 2019
Moldova
46.9%
in 2019
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
9th
Moldova rank
11th

Prevalence of hypertension, female over time

  • Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
  • Moldova
0204060199020042019

How they compare

Moldova currently reports 46.9% against 38.5% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 8.4%.

That makes Moldova's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.

Across all 30 years both countries report, Moldova has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 9th and Moldova ranks 11th of 43 groups.

Moldova has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Moldova Difference Ahead
1990s 38.6% 51.1% 12.5% Moldova
2000s 39.9% 48.9% 9.0% Moldova
2010s 39.4% 47.7% 8.3% Moldova

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hypertension, female, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) or Moldova?
Moldova, at 46.9% against 38.5% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2019.
What is the difference in prevalence of hypertension, female between Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Moldova?
8.4%, with Moldova ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Moldova?
30 years are reported by both, from 1990 to 2019.
How do Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Moldova rank globally for prevalence of hypertension, female?
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 9th and Moldova ranks 11th of 43 groups.
Where does this data come from?
World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, female (% of female adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Moldova: Prevalence of hypertension, female. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 18 September 2026, from https://health.statizoid.com/compare/prevalence-of-hypertension-female-percent-of-female-adults-ages-30-79/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/moldova/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/prevalence-of-hypertension-female-percent-of-female-adults-ages-30-79/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/moldova/">Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Moldova: Prevalence of hypertension, female</a> — Statizoid

About this data

Indicator
Prevalence of hypertension, female (% of female adults ages 30-79)
Unit
% of female adults ages 30-79
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Prevalence of hypertension, female, is the percentage of female adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.